Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.44 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.44 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.44 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.44 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.2.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.2.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.2.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LD.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LD.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LD.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LD.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.1.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KW.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KW.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KW.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KW.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KR.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KR.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KR.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KR.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.15.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.15.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.15.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.15.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.50.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.50.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.50.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.50.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LB.1.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LB.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-14553.9China
LB.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LB.1.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
LF.3.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
LF.3.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
LF.3.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
LF.3.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
JN.1.18.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
JN.1.18.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
JN.1.18.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JN.1.18.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.3.2.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.3.2.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.3.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.3.2.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KP.4.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KP.4.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used